Clinical trial · Interventional
The Effects of Intraoperative Dexmedetomidine Infusion on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy
NCT02164448CI-TRIAL-00018030completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators hypothesized that sympatholytic effect of dexmedetomidine would attenuate the hemodynamic instability and decrease in the splanchnic blood flow caused by pneumoperitoneum during laparoscopic surgery. This study is to investigate the effect of intraoperative dexmedetomidine infusion on postoperative bowel movement in patients undergoing laparoscopic gastrectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer Patients Undergoing Laparoscopic Gastrectomy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| the control group | Drug | — | UNRESOLVED |
| the dexmedetomidine group | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- dexmedetomidine group
- interventionNames
- Drug: the dexmedetomidine group
- type
- PLACEBO_COMPARATOR
- label
- control group
- interventionNames
- Drug: the control group
Primary outcomes (1)
- measure
- gas passing
- timeFrame
- up to 1 week
- description
- To evaluate the postoperative bowel movement, we will assess the time to first gas passing
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * patient between 20 and 65 of age with ASA physical status Ⅰ-Ⅲ * gastric cancer patient undergoing laparoscopic gastrectomy Exclusion Criteria: * ASA physical status Ⅳ * bradycardia (\< 60 bpm), arrhythmia * uncompensated heart failure * hepatic failure (Child-Pugh score B 이상) * renal failure (eGFR MDRD \< 60 ml/min/1.73m2)
References
Publications (0)
Data not yet available
No reference posted for this study.